Capecitabine trials for Rectal Adenocarcinoma

All Capecitabine trials · All Rectal Adenocarcinoma trials

Phase breakdown

Recruiting trials studying Capecitabine for Rectal Adenocarcinoma

• FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
  NCT06780787 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
  NCT04808323 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
  NCT04703101 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra Low Rectal Adenocarcinoma
  NCT06266832 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.
  NCT07407465 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 28 locations

Common questions

How many trials study Capecitabine for Rectal Adenocarcinoma?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.